Clinical Trials Browser

Phase 2/3 × OTHER × Urinary Bladder Neoplasms × Clear all

NCT06851663 2026-05-29

Trop2-targeted immunoPET Imaging of Solid Tumors

Phase 2/3 Recruiting

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT07608224 2026-05-27

HOPE-07-MIBC

Phase 2/3 Not yet recruiting

Urinary Bladder Neoplasms

NCT05786716 2025-12-02

DETERMINE

Phase 2/3 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

Urinary Bladder Neoplasms

NCT01869413 2022-10-04

TACT

Phase 2/3 Completed

Urinary Bladder Neoplasms

NCT02355886 2019-06-04

Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy

Phase 2/3 Completed

25 enrolled 8 charts

Urinary Bladder Neoplasms

NCT01668459 2018-12-04

CabB1

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT03427034 2018-02-09

ABSEIL

Phase 2/3 Unknown

Urinary Bladder Neoplasms, Hematuria, Recurrence

NCT00949455 2015-04-15

LaMB

Phase 2/3 Unknown

Urinary Bladder Neoplasms

NCT00330707 2011-03-04

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Phase 2/3 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms